🇺🇸 FDA
Patent

US 9592221

Antibacterial agents: aryl myxopyronin derivatives

granted A61KA61K31/366A61K31/381

Quick answer

US patent 9592221 (Antibacterial agents: aryl myxopyronin derivatives) held by Provid Pharmaceuticals Inc. expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Provid Pharmaceuticals Inc.
Grant date
Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/366, A61K31/381, A61K31/4025, A61K31/404